Ocient, a trailblazing data analytics software solutions company, is excited to announce that it has raised $159,400,000 in a significant funding round. This capital injection underlines investor confidence in Ocient’s cutting-edge approach to tackling compute-intensive analysis of large, complex datasets while optimizing for performance, cost, and energy efficiency. With its unique consolidated platform, Ocient brings together data transformation, streamlined loading, advanced complex query processing, artificial intelligence, OcientML®, and OcientGeo® into a comprehensive solution that drives deeper insights and data-powered decision-making. Enterprises can efficiently deploy Ocient’s pilot-to-production solutions on premises, through the OcientCloud™, or even on public cloud platforms—all with minimal resource-intensive integration required. Headquartered in Chicago and operating as a global, remote-first, carbon-neutral company, Ocient remains steadfast in its commitment to sustainability while pushing the boundaries of data analytics innovation. The funding will be strategically allocated to bolster product innovation, expand market presence, and further scale operational capabilities. This enables Ocient to continue refining its technology stack and drive enhancements that empower enterprises to extract actionable intelligence from vast troves of data—transforming the way businesses operate in an increasingly complex and data-driven landscape. With the backing of esteemed investors including Greycroft, OCA Ventures, In-Q-Tel, and Buoyant Ventures, Ocient is poised to set new industry standards and forge ahead in revolutionizing data analysis. For those looking to join a team that is making data more efficient at scale, opportunities abound—email recruiting@ocient.com to learn more about joining Ocient’s mission-driven journey.
Ocient Secures $159.4M Series B Funding to Transform High-Performance Data Analytics at Scale
Get the full Ocient company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Digital Asset
Digital Asset is a leading innovator in blockchain technology, transforming traditional and digital financial markets with privacy-enabled solutions that improve capital flow and create a more efficient, fair, and resilient global system. As the creator of the technology that launched the Canton Network, the only public layer one blockchain with privacy, and a founding member of its Global Synchronizer Foundation, Digital Asset has been a pioneer of this open, secure, and interoperable infrastructure. Founded in 2014, Digital Asset is committed to reshaping the future of finance by enabling real-time efficiencies, 24/7 global transactions, and unlocking the full potential of cryptocurrencies, digital assets, and the continued convergence of decentralized and traditional finance. In 2025, Digital Asset was included as a Unicorn in the World Economic Forum’s prestigious Innovator Communities.
$300.0M Unknown
today
White Circle
White Circle is the control layer for AI in production. We help companies test, protect, observe, and improve every AI interaction — from blocking unsafe inputs and preventing jailbreaks to analyzing user behavior and optimizing model performance.
$11.0M Seed
today
Hoplon AI
Human Convesation, Super Human Protection - Always on
$1.0M Seed
today
Isomorphic Labs
Isomorphic Labs is here to advance human health by building on and beyond the Nobel-winning AlphaFold system. Our interdisciplinary team has developed a unified, state-of-the-art drug design engine that will transform how we design new drugs, and ultimately change the way medicine will help and heal people. Every day, and with each new breakthrough, we’re getting closer to achieving our ambitious mission to one day solve all disease
$2.1B Series b
today
Sensible Medical Innovations Ltd.
Sensible Medical has developed a non-invasive fluid status monitor (ReDS) for accurate measurement and monitoring of lung fluid for heart failure patients.
$20.0M Unknown
today
Other recent Series b rounds
Companies that recently closed a Series b round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | Isomorphic Labs United Kingdom | Series b | $2.1B | today |
| 2 |  Invert Robotics Ireland | Series b | $2.7M | today |
| 3 |  Catch Co. United States | Series b | $38.0M | today |
| 4 |  Tarsus Pharmaceuticals, Inc. United States | Series b | $60.0M | today |
| 5 |  Aclaris Therapeutics, Inc. United States | Series b | $21.0M | today |